Atlas Trials

Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients

Clinical trial NCT06034925 · COMPLETED

Trial details

NCT number
NCT06034925
Sponsor
Medical University of South Carolina
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Transplant ComplicationCMV
Start date
2023-11-06
Primary completion
2025-06-30
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.